Innovation for prevention

In 2011, Sanofi Pasteur confirmed its place as the world leader in influenza vaccines. With strong demands in the southern hemisphere, 2011 was a record year with more than 200 million vaccine doses delivered.

Sanofi Pasteur also produces several pediatric combination vaccines that are recommended in vaccination schedules in numerous countries in Europe, in the United States, and in some emerging countries. In 2011 in China, the Group’s vaccines division launched Pentaxim®, an unprecedented combination vaccine that protects against five deadly childhood diseases.

The current development portfolio includes 13 vaccines, some of which are intended specifically for emerging markets. Among these, the development of a dengue vaccine is particularly important for Sanofi.

Read more